Inovio Pharmaceuticals Inc (INO)

05:27 AM

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

05:27 AM

07:40 AM

Bet on These 5 Top-Ranked Stocks With Rising P/E - Yahoo Finance

07:40 AM

Apr 17, 2025

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - ADVFN

Apr 17, 2025

Apr 17, 2025

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2025

Apr 16, 2025

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 16, 2025

Apr 11, 2025

Inovio Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch

Apr 11, 2025

Apr 11, 2025

INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference - MSN

Apr 11, 2025

Apr 11, 2025

INOVIO to Showcase Breakthrough Data on INO-3107 at Major Industry Conferences - MyChesCo

Apr 11, 2025

Apr 10, 2025

Inovio (INO) Upgraded to Buy: Here's What You Should Know - MSN

Apr 10, 2025

Apr 10, 2025

INOVIO Reports Inducement Grant Under Inducement Plan - MarketScreener

Apr 10, 2025

Apr 10, 2025

Next-generation Covid-19 vaccines currently being tested - Yahoo Finance

Apr 10, 2025

Apr 09, 2025

Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 09, 2025

Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences | INO Stock News - GuruFocus

Apr 09, 2025

Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences - Longview News-Journal

Apr 09, 2025

Apr 09, 2025

INOVIO's Breakthrough: 72% Success in HPV TreatmentMultiple Conference Spotlights - Stock Titan

Apr 09, 2025

Apr 08, 2025

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 08, 2025

Apr 07, 2025

Inovio stock touches 52-week low at $1.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Inovio stock touches 52-week low at $1.47 amid market challenges - Investing.com Australia

Apr 07, 2025

Apr 04, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 04, 2025

Apr 04, 2025

Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 - ACCESS Newswire

Apr 04, 2025

Apr 02, 2025

HPV Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR | - openPR.com

Apr 02, 2025

Apr 01, 2025

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO) - Yahoo Finance

Apr 01, 2025

Mar 31, 2025

Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 31, 2025

Mar 31, 2025

Sector Update: Health Care - MarketScreener

Mar 31, 2025

Mar 28, 2025

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Mar 28, 2025

Mar 26, 2025

Inovio stock plunges to 52-week low at $1.74 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Inovio stock plunges to 52-week low at $1.74 amid market challenges - Investing.com Australia

Mar 26, 2025

Mar 25, 2025

Lassa Fever Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | Inovio Pharma - Barchart.com

Mar 25, 2025

Mar 22, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025

Mar 21, 2025

INOVIO Reports Progress on INO-3107 and DNA Medicine, 2024 Financial Outcomes - MSN

Mar 21, 2025

Mar 20, 2025

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Mar 20, 2025

Mar 20, 2025

Inovio’s SWOT analysis: dna firm’s stock faces crucial year ahead By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

DNA Vaccines Market and Their Impact on Global Health: Trends & - openPR.com

Mar 20, 2025

Mar 19, 2025

Inovio’s SWOT analysis: dna firm’s stock faces crucial year ahead - Investing.com

Mar 19, 2025

Mar 19, 2025

Inovio taking on Covid-19 again, almost 3 years after abandoning vaccine effort - Philadelphia Business Journal

Mar 19, 2025

Mar 19, 2025

Inovio aims for INO-3107 regulatory submission by mid-2025 while addressing key manufacturing issues - MSN

Mar 19, 2025

Mar 19, 2025

RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Keeps Sector Perform, Speculative Risk - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo

Mar 19, 2025

Mar 19, 2025

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

Mar 19, 2025